Combination therapy

Results: 292



#Item
141ARTICLES  Age and Risks of FDA–Approved Long-Acting ␤2-Adrenergic Receptor Agonists AUTHORS: Ann W. McMahon, MD, MS,a Mark S. Levenson, PhD,b Bradley W. McEvoy, DrPH,b Andrew D. Mosholder,

ARTICLES Age and Risks of FDA–Approved Long-Acting ␤2-Adrenergic Receptor Agonists AUTHORS: Ann W. McMahon, MD, MS,a Mark S. Levenson, PhD,b Bradley W. McEvoy, DrPH,b Andrew D. Mosholder,

Add to Reading List

Source URL: pediatrics.aappublications.org

Language: English
142GUNS, DOMESTIC VIOLENCE AND HOMICIDE Every day, victims are killed or severely injured due to the lethal combination of guns and domestic violence. A staggering number of women are killed at the hands of their abusers, a

GUNS, DOMESTIC VIOLENCE AND HOMICIDE Every day, victims are killed or severely injured due to the lethal combination of guns and domestic violence. A staggering number of women are killed at the hands of their abusers, a

Add to Reading List

Source URL: nnedv.org

Language: English - Date: 2014-03-27 16:26:42
143US Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee Meeting April 17, 2013 Susan Limb, MD Clinical Team Leader

US Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee Meeting April 17, 2013 Susan Limb, MD Clinical Team Leader

Add to Reading List

Source URL: www.fda.gov

Language: English
144U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

Add to Reading List

Source URL: www.fda.gov

Language: English
145English 2008 Astham DUE bulletin v2.qxp

English 2008 Astham DUE bulletin v2.qxp

Add to Reading List

Source URL: www.csfs.org

Language: English - Date: 2011-06-28 15:33:04
146US Food and Drug Administration.  Pulmonary-Allergy Drugs  Advisory Committee Meeting September 10, 2013

US Food and Drug Administration. Pulmonary-Allergy Drugs Advisory Committee Meeting September 10, 2013

Add to Reading List

Source URL: www.fda.gov

Language: English
147Kansas Drug Utilization Review Newsletter Published by Health Information Designs, Inc. Spring 2010 Welcome to the spring 2010 edition of the “Kansas Drug Utilization Review Newsletter,” published by Health Informati

Kansas Drug Utilization Review Newsletter Published by Health Information Designs, Inc. Spring 2010 Welcome to the spring 2010 edition of the “Kansas Drug Utilization Review Newsletter,” published by Health Informati

Add to Reading List

Source URL: www.kdheks.gov

Language: English - Date: 2012-02-06 11:13:40
148PULMONARY ALLERGY DRUGS ADVISORY COMMITTEE MEETING FDA Briefing Document March 7, 2013

PULMONARY ALLERGY DRUGS ADVISORY COMMITTEE MEETING FDA Briefing Document March 7, 2013

Add to Reading List

Source URL: www.fda.gov

Language: English
149U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

Add to Reading List

Source URL: www.fda.gov

Language: English
150Linear 5ive MOSFET Array Dosimeter  Dynamic Dose Measurements for Brachytherapy Dosimetry MOSFET Array The Linear 5ive MOSFET Array™, when used in combination with

Linear 5ive MOSFET Array Dosimeter Dynamic Dose Measurements for Brachytherapy Dosimetry MOSFET Array The Linear 5ive MOSFET Array™, when used in combination with

Add to Reading List

Source URL: www.mosfet.ca

Language: English - Date: 2010-01-20 15:33:06